Severe and uniform bi-atrial remodeling measured by dominant frequency analysis in persistent atrial fibrillation unresponsive to ablation.

Atrial fibrillation Catheter ablation Dominant frequency Electroanatomical remodeling Intracardiac electrograms Surface ECG

Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 16 10 2019
accepted: 02 12 2019
pubmed: 15 12 2019
medline: 19 8 2021
entrez: 15 12 2019
Statut: ppublish

Résumé

High values of ECG and intracardiac dominant frequency (DF) are indicative of significant atrial remodeling in persistent atrial fibrillation (peAF). We hypothesized that patients with peAF unresponsive to ablation display higher ECG and intracardiac DFs than those remaining in sinus rhythm (SR) on the long term. Forty consecutive patients underwent stepwise ablation for peAF (sustained duration 19 ± 11 months). Electrograms were recorded before ablation at 13 left atrium (LA) sites and at the right atrial appendage (RAA) and coronary sinus (CS) synchronously to the ECG. DF was defined as the highest peak within the power spectrum. peAF was terminated within the LA in 28 patients (left-terminated [LT]), whereas 12 patients remaining in AF after ablation (not left-terminated [NLT]) were cardioverted. Over a mean follow-up of 34 ± 14 months, all 12 NLT patients had a recurrence. Of the LT patients, 71% had a recurrence (20/28, LT_Rec), while 29% remained in SR throughout the follow-up (8/28, LT_SR). DF values and correlations between pairs of LA appendage (LAA), RAA, and CS DFs showed distinctive patterns among the subgroups. The NLT subgroup displayed the highest ECG and intracardiac DFs, with strong intragroup homogeneity between pairs of CS and LAA DFs, and to a lesser extent between pairs of CS and RAA DFs. Conversely, the LT_SR subgroup showed the lowest DFs, with significant intragroup heterogeneity between pairs of CS and both LAA and RAA DFs. Patients with peAF unresponsive to ablation show high surface and intracardiac DFs indicative of severe and uniform bi-atrial remodeling.

Sections du résumé

BACKGROUND BACKGROUND
High values of ECG and intracardiac dominant frequency (DF) are indicative of significant atrial remodeling in persistent atrial fibrillation (peAF). We hypothesized that patients with peAF unresponsive to ablation display higher ECG and intracardiac DFs than those remaining in sinus rhythm (SR) on the long term.
METHODS METHODS
Forty consecutive patients underwent stepwise ablation for peAF (sustained duration 19 ± 11 months). Electrograms were recorded before ablation at 13 left atrium (LA) sites and at the right atrial appendage (RAA) and coronary sinus (CS) synchronously to the ECG. DF was defined as the highest peak within the power spectrum.
RESULTS RESULTS
peAF was terminated within the LA in 28 patients (left-terminated [LT]), whereas 12 patients remaining in AF after ablation (not left-terminated [NLT]) were cardioverted. Over a mean follow-up of 34 ± 14 months, all 12 NLT patients had a recurrence. Of the LT patients, 71% had a recurrence (20/28, LT_Rec), while 29% remained in SR throughout the follow-up (8/28, LT_SR). DF values and correlations between pairs of LA appendage (LAA), RAA, and CS DFs showed distinctive patterns among the subgroups. The NLT subgroup displayed the highest ECG and intracardiac DFs, with strong intragroup homogeneity between pairs of CS and LAA DFs, and to a lesser extent between pairs of CS and RAA DFs. Conversely, the LT_SR subgroup showed the lowest DFs, with significant intragroup heterogeneity between pairs of CS and both LAA and RAA DFs.
CONCLUSIONS CONCLUSIONS
Patients with peAF unresponsive to ablation show high surface and intracardiac DFs indicative of severe and uniform bi-atrial remodeling.

Identifiants

pubmed: 31836965
doi: 10.1007/s10840-019-00681-1
pii: 10.1007/s10840-019-00681-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-440

Subventions

Organisme : Kommission für Technologie und Innovation
ID : 18265.1 PFLS-LS
Organisme : Swiss National Science Foundation
ID : SNF 205321
Pays : Switzerland

Auteurs

Adrian Luca (A)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Anthony Pittet (A)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Andréa Buttu (A)

Applied Signal Processing Group, Swiss Federal Institute of Technology, Lausanne, Switzerland.

Anna McCann (A)

Applied Signal Processing Group, Swiss Federal Institute of Technology, Lausanne, Switzerland.

Jean-Marc Vesin (JM)

Applied Signal Processing Group, Swiss Federal Institute of Technology, Lausanne, Switzerland.

Patrizio Pascale (P)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Mathieu Le Bloa (M)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Claudia Herrera (C)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Chan-Il Park (CI)

Department of Cardiology, Hôpital de La Tour, Geneva, Switzerland.

Anne Rollin (A)

Service of Cardiology, Centre Universitaire de Rangueil, Toulouse, France.

Philippe Maury (P)

Service of Cardiology, Centre Universitaire de Rangueil, Toulouse, France.

Laurent Roten (L)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Michael Kühne (M)

Department of Cardiology, University Hospital of Basel, Basel, Switzerland.

Florian Spies (F)

Department of Cardiology, University Hospital of Basel, Basel, Switzerland.

Sven Knecht (S)

Department of Cardiology, University Hospital of Basel, Basel, Switzerland.

Christian Sticherling (C)

Department of Cardiology, University Hospital of Basel, Basel, Switzerland.

Etienne Pruvot (E)

Service of Cardiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland. etienne.pruvot@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH